Vomiren 0.25 mg/5 ml (IV Injection)
5 ml ampoule: ৳ 100.00 (1 x 5: ৳ 500.00)
Medicine Details
Category | Details |
---|---|
Generic | Palonosetron |
Company | Renata limited |
Also available as |
Indications
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV)
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV)
Pharmacology
- 5-HT3 receptor antagonist
- Binding affinity for 5-HT3 receptor
- Pharmacokinetics
- Metabolism via kidney and liver enzymes
- Plasma protein binding
Dosage & Administration
- Adult tablet dosage: 0.5 mg daily
- Adult IV dosage: 0.075 mg over 10 seconds
- Dosage prior to chemotherapy and radiotherapy
- Children dosage: 20 mcg/kg body weight
Interaction
- Safety with corticosteroids and analgesics
- No inhibition of antitumor activity
- No significant pharmacokinetic interactions
- Inhibition of CYP enzymes
Contraindications
- Hypersensitivity to the drug or its components
Side Effects
- Headaches
- Constipation
Pregnancy & Lactation
- Pregnancy category 'B'
- Excretion in breast milk unknown
Use in Special Populations
- No dosage adjustment in elderly patients
- Dosage in children
- No dosage adjustment in patients with renal and hepatic dysfunction
Overdose Effects
- No known antidote
- Supportive care management
Therapeutic Class
- Anti-emetic drugs
Storage Conditions
- Cool & dry place
- Protected from light
Related Brands
- Paloron ODT 0.5 mg (Dispersible Tablet) - ziska-pharmaceuticals-ltd
- Vomiren 0.5 mg (Capsule) - renata-limited
- Palotic 0.25 mg/5 ml (IV Injection) - popular-pharmaceuticals-ltd
- Palosis 0.25 mg/5 ml (IV Injection) - eskayef-pharmaceuticals-ltd
- Paloxi ODT 0.5 mg (Dispersible Tablet) - beacon-pharmaceuticals-plc